Paper346283
Clinical pharmacokinetics of methotrexate.
Shen DD and 1 other. Clin Pharmacokinet, 1978. Cited by 217 papers, by iCite.
Cite this record
ConductScience Library. Clinical pharmacokinetics of methotrexate. Papers, record 346283. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/346283
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Methotrexate | Major topic |
| Administration, Oral | |
| Bile | |
| Blood Proteins | |
| Cell Membrane | |
| Central Nervous System | |
| Drug Administration Schedule | |
| Drug Combinations | |
| Erythrocytes | |
| Humans | |
| Injections, Intramuscular | |
| Kidney | |
| Kinetics | |
| Neoplasms | |
| Protein Binding | |
| Psoriasis |
Source PubMed
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 52104 | Letter: Purity of methotrexate. | Lancet | 1975 | https://conductscience.org/library/papers/52104 | PubMed |
| 2 | 1182692 | Tissue-specific synthesis of methotrexate polyglutamates in the rat. | Cancer Res | 1975 | https://conductscience.org/library/papers/1182692 | PubMed |
| 3 | 4197190 | Polygammaglutamyl metabolites of methotrexate. | Biochem Biophys Res Commun | 1973 | https://conductscience.org/library/papers/4197190 | PubMed |
| 4 | 5349626 | The effect of organic acids on renal clearance of methotrexate in man. | Clin Pharmacol Ther | 1969 | https://conductscience.org/library/papers/5349626 | PubMed |
| 5 | 832268 | The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continuous methotrexate infusion. | Cancer Res | 1977 | https://conductscience.org/library/papers/832268 | PubMed |
| 6 | 4284746 | The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man. | Cancer Res | 1965 | https://conductscience.org/library/papers/4284746 | PubMed |
| 7 | 5289428 | The characteristics of the membrane transport of amethopterin and the naturally occurring folates. | Ann N Y Acad Sci | 1971 | https://conductscience.org/library/papers/5289428 | PubMed |
| 8 | 14149915 | METHOTREXATE DISPLACEMENT IN MAN. | J Clin Invest | 1964 | https://conductscience.org/library/papers/14149915 | PubMed |
| 9 | 1131258 | Stoichiometric inhibition of mammalian dihydrofolate reductase by the gamma-glutamyl metabolite of methotrexiate, 4-amino-4-deoxy-N-10-methylpteroylglutamyl-gamma-glutamate. | Biochem Biophys Res Commun | 1975 | https://conductscience.org/library/papers/1131258 | PubMed |
| 10 | 4723265 | Pharmacokinetics of methotrexate. | Clin Pharmacol Ther | 1973 | https://conductscience.org/library/papers/4723265 | PubMed |
| 11 | 5289427 | Metabolism of folate antagonists. | Ann N Y Acad Sci | 1971 | https://conductscience.org/library/papers/5289427 | PubMed |
| 12 | 5345205 | Antibiotics alter methotrexate metabolism and excretion. | Science | 1969 | https://conductscience.org/library/papers/5345205 | PubMed |
| 13 | 1109785 | Inhibition of renal tubular transport of methotrexate by probenecid. | Cancer Res | 1975 | https://conductscience.org/library/papers/1109785 | PubMed |
| 14 | 4429965 | Effect of route of administration and effusions on methotrexate pharmacokinetics. | Cancer Res | 1974 | https://conductscience.org/library/papers/4429965 | PubMed |
| 16 | 4517004 | Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia. | N Engl J Med | 1973 | https://conductscience.org/library/papers/4517004 | PubMed |
| 17 | 1062383 | 7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate. | J Clin Invest | 1976 | https://conductscience.org/library/papers/1062383 | PubMed |
| 18 | 806016 | Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. | N Engl J Med | 1975 | https://conductscience.org/library/papers/806016 | PubMed |
| 19 | 1175171 | Kinetic model for the disposition and metabolism of moderate and high-dose methotrexate (NSC-740) in man. | Cancer Chemother Rep | 1975 | https://conductscience.org/library/papers/1175171 | PubMed |
| 20 | 1273152 | The synergistic effect of salicylates on methotrexate toxicity. | Plast Reconstr Surg | 1976 | https://conductscience.org/library/papers/1273152 | PubMed |
| 21 | 5042796 | Secretion of methotrexate into human milk. | Am J Obstet Gynecol | 1972 | https://conductscience.org/library/papers/5042796 | PubMed |
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 217 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41954735 | Half-dose glucarpidase: an effective rescue for toxic methotrexate plasma concentrations in a patient with bilateral primary vitreoretinal lymphoma. | Ann Hematol | 2026 | https://conductscience.org/library/papers/41954735 | PubMed |
| 41950802 | Emerging mechanistic trends and clinical efficacy for methotrexate: Applications to inflammatory bowel disease. | Pharmacol Rev | 2026 | https://conductscience.org/library/papers/41950802 | PubMed |
| 40601470 | Prescribing Inflammatory Bowel Disease Medications in Chronic Kidney Disease: A Practical Guide. | Aliment Pharmacol Ther | 2025 | https://conductscience.org/library/papers/40601470 | PubMed |
| 39403008 | Is the GFR-based scaling approach adequate for predicting pediatric renal clearance of drugs with passive tubular reabsorption? Insights from PBPK modeling. | CPT Pharmacometrics Syst Pharmacol | 2025 | https://conductscience.org/library/papers/39403008 | PubMed |
| 38303016 | Drug-drug interaction assessment based on a large-scale spontaneous reporting system for hepato- and renal-toxicity, and thrombocytopenia with concomitant low-dose methotrexate and analgesics use. | BMC Pharmacol Toxicol | 2024 | https://conductscience.org/library/papers/38303016 | PubMed |
| 37934204 | Factors influencing methotrexate pharmacokinetics highlight the need for individualized dose adjustment: a systematic review. | Eur J Clin Pharmacol | 2024 | https://conductscience.org/library/papers/37934204 | PubMed |
| 37446715 | Rhodiola rosea L. Extract, a Known Adaptogen, Evaluated in Experimental Arthritis. | Molecules | 2023 | https://conductscience.org/library/papers/37446715 | PubMed |
| 35236714 | Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup. | Clin J Am Soc Nephrol | 2022 | https://conductscience.org/library/papers/35236714 | PubMed |
| 34669022 | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury. | Cancer Chemother Pharmacol | 2022 | https://conductscience.org/library/papers/34669022 | PubMed |
| 34200242 | Systematic Review of Pharmacogenetic Factors That Influence High-Dose Methotrexate Pharmacokinetics in Pediatric Malignancies. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34200242 | PubMed |
| 33177476 | Methotrexate Decreases Tenofovir Exposure in Antiretroviral-Suppressed Individuals Living With HIV. | J Acquir Immune Defic Syndr | 2020 | https://conductscience.org/library/papers/33177476 | PubMed |
| 32982497 | Risk Factors Associated with Methotrexate Intolerance in Rheumatoid Arthritis Patients. | Open Access Rheumatol | 2020 | https://conductscience.org/library/papers/32982497 | PubMed |
| 32699674 | High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia: Predictors of Delayed Clearance and the Effect of Increased Hydration Rate on Methotrexate Clearance. | Cureus | 2020 | https://conductscience.org/library/papers/32699674 | PubMed |
| 31890337 | Analytical methodologies for determination of methotrexate and its metabolites in pharmaceutical, biological and environmental samples. | J Pharm Anal | 2019 | https://conductscience.org/library/papers/31890337 | PubMed |
| 29512050 | Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease. | Clin Pharmacokinet | 2018 | https://conductscience.org/library/papers/29512050 | PubMed |
| 28148280 | Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial. | Trials | 2017 | https://conductscience.org/library/papers/28148280 | PubMed |
| 26457382 | Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases. | Inflamm Bowel Dis | 2016 | https://conductscience.org/library/papers/26457382 | PubMed |
| 25004821 | Predicting when biliary excretion of parent drug is a major route of elimination in humans. | AAPS J | 2014 | https://conductscience.org/library/papers/25004821 | PubMed |
| 24433481 | Urinary coproporphyrin I/(I + III) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance. | Br J Clin Pharmacol | 2014 | https://conductscience.org/library/papers/24433481 | PubMed |
| 22950522 | Pharmacokinetics, safety, and tolerability of GLPG0259, a mitogen-activated protein kinase-activated protein kinase 5 (MAPKAPK5) inhibitor, given as single and multiple doses to healthy male subjects. | Drugs R D | 2012 | https://conductscience.org/library/papers/22950522 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/346283
GET https://conductscience.org/api/papers/v1/346283/references?page=2